LEQVIO

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: b1a5282a0e98b61d
Drug Approval Canada Name: LEQVIO
Product Name: LEQVIO
Status: Marketed
Status Date: 2022-09-26
Original Market Date: 2022-09-26
Din: 02518376
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription
Atc Original: C10AX16 INCLISIRAN
Atc Name: c 10 ax 16
Aig Number: 0163074001
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

INCLISIRAN (INCLISIRAN)

284 MG / 1.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b1a5282a0e98b61d

Type

Standard